Tag: AI drug discovery
AI Drug Development Faces Reality Check as BigHat CEO Debunks Industry Hype
BigHat Biosciences CEO warns that misconceptions about AI capabilities threaten genuine progress in computational drug discovery. Despite $50 billion annual…
Submit Your Paper to GMJ
No APC until January 2027.